Jeff Eiseman
Long only, deep value, special situations

What The Judge's Award Means For PharmAthene's Value/Share: A Data-Based Analysis

Friday night, Vice Chancellor Parsons wrote his opinion in the on-going legal dispute between PharmAthene (NYSEMKT:PIP) and SIGA Technologies (NASDAQ:SIGA). Parsons issued two documents: a 55-page memo describing his remedy for SIGA's breach of its contractual obligation to negotiate in good faith and a much shorter implementing order that provided the details for how the award was to be calculated.

In 2011, he imposed an income stream remedy, but SIGA appealed. Last May, the Supreme Court upheld his finding that SIGA had breached its contractual obligation, but remanded the remedy. There were several issues, including that the remedy needed to be based on contract law, and that the remedy needed to be based upon the two...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details